Seres Therapeutics has reported that SER-287 failed to meet the primary goal of clinical remission in the Phase IIb ECO-RESET…
23 Jul 2021
Adagene partners with Merck on combination treatment for cancer
Adagene has signed a clinical trial collaboration and supply agreement with Merck (MSD) to assess its drug candidates, ADG116 and ADG126, in combination with the latter’s Keytruda (pembrolizumab) for the…
23 Jul 2021
eFFECTOR begins dosing in Phase Ib trial of zotatifin in Covid-19
eFFECTOR Therapeutics has dosed the first participant in the Phase Ib clinical trial of zotatifin (eFT226) to treat outpatients with mild to moderate Covid-19. The trial is funded by a…
23 Jul 2021
Humanigen’s partners get approval to trial lenzilumab in South Korea
South Korea’s Ministry of Food and Drug Safety (MFDS) has granted approval to Humanigen’s partners, Telcon RF Pharmaceutical and KPM Tech, to carry out Phase I clinical trial of lenzilumab…
22 Jul 2021
Sorrento doses subjects in Covid-19 trial of intranasal drug in the UK
Sorrento Therapeutics has dosed subjects in Phase II trial of its intranasal drug, COVIDROPS, for the treatment of Covid-19 in the outpatient setting in the UK. A neutralising antibody drug…
22 Jul 2021
FDA places clinical hold on Magenta’s Phase I/II leukaemia trial
The US Food and Drug Administration (FDA) has issued a clinical hold letter for Magenta Therapeutics’ investigational new drug application to conduct a Phase I/II clinical trial of MGTA-117. Magenta…
22 Jul 2021
Oravax to commence trials of oral Covid-19 vaccine in Israel
Oramed Pharmaceuticals’s Oravax is set to initiate clinical trials of its oral Covid-19 vaccine in Israel with the study protocol approved by the Institutional Review Board (IRB) at Ichilov Hospital…
© Copyright Verdict Media Limited 2021
Powered by
